Healthcare provider profile · identity verified

Hemlata Bhaskar, M.D.

Internal Medicine · ADRIAN, MI · NPI 1134385941

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1064	278
Levothyroxine Sodium	Levothyroxine Sodium	606	141
Omeprazole	Omeprazole	573	151
Lisinopril	Lisinopril	528	135
Amlodipine Besylate	Amlodipine Besylate	486	130
Rosuvastatin Calcium	Rosuvastatin Calcium	475	130
Losartan Potassium	Losartan Potassium	450	122
Metformin Hcl	Metformin Hcl	428	119
Metoprolol Succinate	Metoprolol Succinate	372	93
Hydrochlorothiazide	Hydrochlorothiazide	348	96
Simvastatin	Simvastatin	295	77
Potassium Chloride	Potassium Chloride	258	87
Alendronate Sodium	Alendronate Sodium	245	70
Metoprolol Tartrate	Metoprolol Tartrate	241	68
Eliquis	Apixaban	234	55
Glipizide	Glipizide	216	58
Sertraline Hcl	Sertraline Hcl	198	56
Gabapentin	Gabapentin	196	67
Jardiance	Empagliflozin	189	38
Carvedilol	Carvedilol	179	50
Famotidine	Famotidine	178	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	161	36
Duloxetine Hcl	Duloxetine Hcl	148	44
Trazodone Hcl	Trazodone Hcl	148	45
Prednisone	Prednisone	133	96
Pantoprazole Sodium	Pantoprazole Sodium	132	42
Citalopram Hbr	Citalopram Hydrobromide	127	33
Furosemide	Furosemide	122	40
Albuterol Sulfate Hfa	Albuterol Sulfate	111	38
Fluticasone Propionate	Fluticasone Propionate	109	43
Allopurinol	Allopurinol	105	36
Pravastatin Sodium	Pravastatin Sodium	105	31
Tamsulosin Hcl	Tamsulosin Hcl	102	22
Warfarin Sodium	Warfarin Sodium	101	23
Spironolactone	Spironolactone	99	30
Xarelto	Rivaroxaban	95	20
Ozempic	Semaglutide	93	20
Buspirone Hcl	Buspirone Hcl	84	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	20
Escitalopram Oxalate	Escitalopram Oxalate	80	24
Ezetimibe	Ezetimibe	77	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	20
Venlafaxine Hcl Er	Venlafaxine Hcl	72	19
Azithromycin	Azithromycin	71	67
Mirtazapine	Mirtazapine	69	22
Atenolol	Atenolol	66	20
Finasteride	Finasteride	63	17
Oxybutynin Chloride Er	Oxybutynin Chloride	61	18
Alprazolam	Alprazolam	59	13
Bumetanide	Bumetanide	58	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	58	52
Trulicity	Dulaglutide	56	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	16
Montelukast Sodium	Montelukast Sodium	53	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	14
Lorazepam	Lorazepam	50	11
Estradiol	Estradiol	46	13
Hydralazine Hcl	Hydralazine Hcl	45	12
Fluoxetine Hcl	Fluoxetine Hcl	44	12
Synthroid	Levothyroxine Sodium	44	12
Donepezil Hcl	Donepezil Hcl	42	suppressed
Pregabalin	Pregabalin	42	13
Bisoprolol Fumarate	Bisoprolol Fumarate	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	13
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Propranolol Hcl Er	Propranolol Hcl	41	suppressed
Ibuprofen	Ibuprofen	40	15
Meloxicam	Meloxicam	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	12
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	38	11
Lansoprazole	Lansoprazole	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Klor-Con M20	Potassium Chloride	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Nifedipine Er	Nifedipine	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	17
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Valsartan	Valsartan	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Ondansetron Odt	Ondansetron	29	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	28
Aripiprazole	Aripiprazole	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	15
Hydroxyzine Hcl	Hydroxyzine Hcl	28	18
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	25
Latanoprost	Latanoprost	25	suppressed
Methylprednisolone	Methylprednisolone	25	21
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Acyclovir	Acyclovir	24	11
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	18
Januvia	Sitagliptin Phosphate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	14
Calcitriol	Calcitriol	22	suppressed
Cephalexin	Cephalexin	22	21
Clonazepam	Clonazepam	22	suppressed
Fluconazole	Fluconazole	22	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Cefuroxime	Cefuroxime Axetil	20	19
Jantoven	Warfarin Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Baclofen	Baclofen	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Naproxen	Naproxen	19	11
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ramipril	Ramipril	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Klor-Con M10	Potassium Chloride	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lactulose	Lactulose	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error